PropertyValue
is ?:annotates of
?:creator
?:journal
  • Oncology_Research_and_Treatment
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • The JAK1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
?:type
?:who_covidence_id
  • #881955
?:year
  • 2020

Metadata

Anon_0  
expand all